We are proud to announce a new Collection is open for submissions, edited by Kristian Steen Frederiksen and Paul C. Donaghy. We welcome research articles and reviews, highlighting biomarker discovery, imaging techniques, treatment strategies, and disease pathophysiology in Lewy body dementia.
Find out more about the included topics!
Image credit: © selvanegra / iStock / Getty Images Plus
Interested in an introduction to peer reviewing articles for Alzheimer's Research & Therapy?
Find out more about our ECR Peer Reviewer Panel!
Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports.
Although the primary focus is Alzheimer's disease, the scope encompasses translational research into other neurodegenerative diseases.
The Correction to this article has been published in Alzheimer's Research & Therapy 2022 14:70
Citation Impact
Journal Impact Factor: 7.6 (2024)
5-year Journal Impact Factor: 8.8 (2024)
Source Normalized Impact per Paper (SNIP): 1.763 (2024)
SCImago Journal Rank (SJR): 2.709 (2024)
Speed
Submission to first editorial decision (median days): 8
Submission to acceptance (median days): 125
Usage 2024
Downloads: 2,465,261
Altmetric mentions: 2,432
Alzheimer's Research & Therapy